Molecular Responses with Ponatinib in Patients with Philadelphia Chromosome Positive (Ph+) Leukemia: Results From the PACE Trial

MLA

Hochhaus, Andreas, et al. “Molecular Responses with Ponatinib in Patients with Philadelphia Chromosome Positive (Ph+) Leukemia: Results From the PACE Trial.” Blood, vol. 120, no. 21, Nov. 2012, p. 3763. EBSCOhost, https://doi.org/10.1182/blood.V120.21.3763.3763.

APA

Hochhaus, A., Kim, D.-W., Pinilla-Ibarz, J., le Coutre, P., Paquette, R., Chuah, C., Nicolini, F. E., Apperley, J., Khoury, H. J., Talpaz, M., DiPersio, J. F., DeAngelo, D., Abruzzese, E., Rea, D., Baccarani, M., Muller, M. C., Gambacorti-Passerini, C., Wong, S., Lustgarten, S., … Cortes, J. E. (2012). Molecular Responses with Ponatinib in Patients with Philadelphia Chromosome Positive (Ph+) Leukemia: Results From the PACE Trial. Blood, 120(21), 3763. https://doi.org/10.1182/blood.V120.21.3763.3763

Chicago

Hochhaus, Andreas, Dong-Wook Kim, Javier Pinilla-Ibarz, Philipp le Coutre, Ronald Paquette, Charles Chuah, Franck E. Nicolini, et al. 2012. “Molecular Responses with Ponatinib in Patients with Philadelphia Chromosome Positive (Ph+) Leukemia: Results From the PACE Trial.” Blood 120 (21): 3763. doi:10.1182/blood.V120.21.3763.3763.